Stay updated on AVA6000 in Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AVA6000 in Solid Tumours Clinical Trial page.
Latest updates to the AVA6000 in Solid Tumours Clinical Trial page
- CheckyesterdayChange DetectedDifference0.5%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.4%
- Check16 days agoChange DetectedDifference0.5%
- Check23 days agoChange DetectedThe webpage has undergone significant updates regarding the clinical study of AVA6000, including changes to the study's design, patient eligibility criteria, and the timeline for the study. Notably, the study's start date has been updated to April 10, 2025, and the inclusion criteria have been refined.SummaryDifference55%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 18, 2024.SummaryDifference1%
- Check37 days agoChange DetectedThe page has been updated to include information on Ovarian Epithelial Cancer and has a new last update date of March 25, 2025, while removing references to Transitional Cell Carcinoma and an estimated last update date of December 18, 2024.SummaryDifference0.7%
Stay in the know with updates to AVA6000 in Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVA6000 in Solid Tumours Clinical Trial page.